Quantification of increased biologically active CXCL12α plasma concentrations after ACKR3 antagonist treatment in humans

ABSTRACT:

SUBMITTER: Blattmann P 

PROVIDER: S-EPMC10818162 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature